Scarica l'app Stockscreener
11.51
4.69%
0.515
Dopo l'orario di chiusura:
11.27
-0.235
-2.04%
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché RNAZ Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$10.99
Aprire:
$10.77
Volume 24 ore:
13,783
Relative Volume:
0.25
Capitalizzazione di mercato:
$9.59M
Reddito:
-
Utile/perdita netta:
$-14.93M
Rapporto P/E:
-0.0432
EPS:
-266.137
Flusso di cassa netto:
$-15.87M
1 W Prestazione:
+0.04%
1M Prestazione:
+32.47%
6M Prestazione:
-96.19%
1 anno Prestazione:
-95.28%
Intervallo 1D:
$10.77
$11.51
Intervallo di 1 settimana:
$10.16
$11.70
Portata 52W:
$6.1478
$739.20
Transcode Therapeutics Inc Stock (RNAZ) Company Profile
Nome
Transcode Therapeutics Inc
Settore
Industria
Telefono
857-301-6857
Indirizzo
6 LIBERTY SQUARE, BOSTON
Confronta RNAZ con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RNAZ
Transcode Therapeutics Inc
|
11.51 | 8.66M | 0 | -14.93M | -15.87M | -266.14 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.77 | 93.98B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
556.55 | 59.67B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.93 | 57.53B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
637.56 | 40.50B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.10 | 34.26B | 3.81B | -644.79M | -669.77M | -6.24 |
Transcode Therapeutics Inc Borsa (RNAZ) Ultime notizie
Can momentum traders help lift TransCode Therapeutics Inc.Free Fundamental + Technical Hybrid Stock Tips - Newser
Using Ichimoku Cloud for TransCode Therapeutics Inc. technicalsAI Trading Forecast Based on Big Data - Newser
Building trade automation scripts for TransCode Therapeutics Inc.Deep Learning Stock Forecast for Investors - Newser
What makes TransCode Therapeutics Inc. stock price move sharplyReal-Time Equity Price Action Analysis - Newser
Using data models to predict TransCode Therapeutics Inc. stock movementFree AI Driven Stock Trend Forecast - Newser
Understanding TransCode Therapeutics Inc.’s price movementWeekly Growth Portfolio Performance Summary - Newser
When is the best time to exit TransCode Therapeutics Inc.Chart Driven Opportunity Scanner with Alerts - Newser
Top Risks to Consider Before Buying TransCode Therapeutics Inc. StockFree Weekly Potential Breakout Stock List - Newser
Is TransCode Therapeutics Inc. the Top Chart Pick This WeekTrade Scanner With Buy Zone Alerts Flagged - metal.it
Why ATCO.PRH stock attracts strong analyst attentionMarket Sentiment Tracker with Smart Alerts - Newser
Is TransCode Therapeutics Inc. a growth stock or a value stockCapitalize on momentum-driven opportunities - Jammu Links News
Does TransCode Therapeutics Inc. stock perform well during market downturnsExceptional profit margins - Jammu Links News
Is it the right time to buy TransCode Therapeutics Inc. stockTremendous return on equity - Jammu Links News
When is TransCode Therapeutics Inc. stock expected to show significant growthMaximize your portfolio’s earning potential - Jammu Links News
Why is TransCode Therapeutics Inc. stock attracting strong analyst attentionCapitalize on fast-growing investment opportunities - Jammu Links News
How does TransCode Therapeutics Inc. compare to its industry peersCapitalize on fast-moving trading opportunities - Jammu Links News
What institutional investors are buying TransCode Therapeutics Inc. stockBuild a winning investment portfolio - Jammu Links News
How volatile is TransCode Therapeutics Inc. stock compared to the marketUnprecedented growth rates - Jammu Links News
Relative strength of TransCode Therapeutics Inc. in sector analysisAI Screener Based Stock Summary Report - Newser
Will TransCode Therapeutics Inc. stock benefit from interest rate changesFree Low Risk Swing Trade Opportunity List - Newser
Using RSI to spot recovery in TransCode Therapeutics Inc.Triple Digit Gain Opportunity Watchlist - Newser
Analyzing recovery setups for TransCode Therapeutics Inc. investorsFree Trade Setups With AI Powered Filters - Newser
Signal strength of TransCode Therapeutics Inc. stock in tech scannersWatchlist Generator With Real-Time Entry - Newser
Candlestick signals on TransCode Therapeutics Inc. stock todayOptimized Watchlist With Daily Adjustments Launched - metal.it
Will breakout in TransCode Therapeutics Inc. lead to full recoveryFree Trend Following Strategy With Stop Loss - Newser
TransCode Therapeutics Inc. Company’s Quarterly Earnings Growth: What the Numbers SayEntry Optimization Tool with Screener Logic - Newser
Using flow based indicators on TransCode Therapeutics Inc.Technical Trend Forecast for Investors - Newser
Should you hold or exit TransCode Therapeutics Inc. nowMinimal Risk Growth Investment Opportunity Analysis - Newser
Real time alert setup for TransCode Therapeutics Inc. performanceVolume Spike Detection for Early Breakouts - Newser
Why TransCode Therapeutics Inc. stock attracts strong analyst attentionValue Investing Picks With Stability Outlined - metal.it
What’s next for TransCode Therapeutics Inc. stock priceStrong Buy With Technical Confidence Supported - metal.it
Is TransCode Therapeutics Inc. Stock a Good Fit for Conservative InvestorsFree Alpha Focused Technical Trade Signals - Newser
TransCode Therapeutics Inc. stock outlook for YEARFree High Growth Low Risk Stock Selection - Newser
How does TransCode Therapeutics Inc. generate profit in a changing economyMassive portfolio appreciation - Jammu Links News
What are analysts’ price targets for TransCode Therapeutics Inc. in the next 12 monthsRapid growth trajectories - jammulinksnews.com
DSGR stock prediction for this week Free Trade Scanner With Buy Zone Alerts - Newser
Candlestick signals on TransCode Therapeutics Inc. stock today Long-Term Investment Strategy Summary Guide - Newser
How many analysts rate TransCode Therapeutics Inc. as a “Buy”Discover undervalued stocks before they soar - jammulinksnews.com
What is the dividend policy of TransCode Therapeutics Inc. stockRealize exceptional returns through smart trading - Jammu Links News
Transcode Therapeutics Inc Azioni (RNAZ) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.91%
3.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):